Molecular TESTS (pcr)

• Staphylococcus aureus
• Streptococcus pneumoniae
• Klebsiella pneumoniae
• Mycoplasma pneumoniae
• Salmonella spp.
• Streptococcus pyogens
• Bordetella spp.
• Chlamydia pneumoniae
• Streptococcus agalactiae
• Acinetobacter baumanii
• Pseudomonas aeruginosa
• Legionella pneumophila
• Haemophilius influenzae A–F
• Moraxella catarrhalis
• Human Parechovirus
• Human Coronavirus (alpha and beta)
• Parainfluenza 1–4
• Influenza A Virus
• Enterovirus
• H3N2 Virus
• Human Metapneumovirus (A & B)
• Pandemic H1 Influenza Virus
• Influenza B Virus
• Influenza C Virus
• Adenovirus
• Human Respiratory Syncytial Virus (A & B)
• Human Rhinovirus and Human Bocavirus

Tropical Fever Panel

• Dengue Virus
• Chikungunya Virus
• West Nile Virus
• Salmonella Spp
• Plasmodium Spp
• Rickettsia Spp
• Leptospira Spp
• HPV PCR with 16/18 Genotyping
• Hepatitis C Viral Load
• TB PCR with RIF Resistance
• HLA B27 by PCR
• Hepatitis B Viral Load
• PAN Neurotropic Virus Panel

Immunofluorescence Assay (IFA)

Due to its high sensitivity and specificity, the indirect immunofluorescence test (IIFT) using human epithelial cells (HEp-2) and primate liver is the gold standard for the detection of anti-nuclear autoantibodies (ANA). The signal intensities of a positive and a negative sample differ significantly and microscopic evaluation allows an exact determination of how the indicator dye (usually fluorescein) is spread in the tissue or cells. Each bound autoantibody causes a typical fluorescence pattern, depending on the location of the corresponding autoantigen. If the analysis result is positive, test substrates with defined single antigens (ELISA, western blot, line blot) are used for further differentiation.

AVAILABLE PARAMETERS

• Anti Nuclear Antibody (ANA)
• Liver Kidney Microsome Type 1 (LKM-1)
• Anti Smooth Muscle Antibody (ASTHMA)
• Antimitochondrial Antibodies (AMA)

High Performance Liquid Chromatography(HPLC)

GLYCATED HAEMOGLOBIN (HbA1c)

Our HPLC technology provides both a numerical result and a visual picture of the separated hemoglobins, distinguishing hemoglobin fractions based on charge differences. Other methods cannot provide this clinical information. A chromatogram helps clinicians see potential interferences that may affect their patients’ HbA1c results and help explain discordant results in the presence of interferences so they can choose the appropriate treatment.

AVAILABLE PARAMETERS

• Anti Nuclear Antibody (ANA)
• Liver Kidney Microsome Type 1 (LKM-1)
• Anti Smooth Muscle Antibody (ASTHMA)
• Antimitochondrial Antibodies (AMA)

NABH Related Services

• HIC Committee (Hospital Infection Control Committee)
• ICN Training (Infection Control Nurse)
• Staff Training
• Hospital Antibiotic Policy
• OT Anaerobic and Settle Plate Reports